AATF has been shown to be overexpressed in a variety of cancer tissues, such as breast cancer, multiple myeloma, leukemia, lung cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma, and its level increases during disease progression [9, 10, 28–33]. The gene discussed is AATF; the disease is plasma cell myeloma.